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Abstract  Commercially available wrist-worn heart rate (HR) monitors have become increasingly popular. 
However, the accuracy of the devices across a range of exercise intensities is largely unknown. This study 
investigated the accuracy of four wrist-worn HR monitors (Apple Watch Series 1, Fitbit Charge, TomTom Touch, 
and Mio Fuse). Eighteen adults completed three trials on a cycle ergometer wearing a chest-worn HR monitor 
(Polar). Trial 1 established the HR-power output relationship, and resting and maximum HR. In trials 2 and 3, 
participants were fitted to an electrocardiogram (ECG) and completed a step test consisting of 5 x 3 minute stages at 
40 - 80% of HR reserve (determined in trial 1) whilst wearing two wrist-worn HR monitors. Relative to ECG, there 
were no differences in HR between the devices during exercise (p = 0.239), and no device × exercise intensity 
interaction (p = 0.370). There were no instances where ECG and Polar data differed by ≥ 5 b·min-1. Conversely, 
there were two instances (2.2%) with the Apple, four (4.4%) with the Mio, 10 (11.1%) with the TomTom, and 19 
(21.1%) with the Fitbit. A chest-worn HR monitor offers greater accuracy compared to wrist-worn devices. 
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1. Introduction 
The measurement of heart rate (HR) is widely used to 
monitor the intensity of physical activity (PA), devise 
exercise programmes based on HR training zones  
[1,2] and estimate cardiorespiratory fitness (CRF). [3] 
Technological advances since the early 1980s have led to 
the development of commercially available HR monitors, 
which consist of a chest strap (transmitter) that 
communicates with a watch (receiver) via telemetry, 
providing a continuous reading of HR. [4] These devices 
are reported to produce valid and reliable HR data when 
compared against an electrocardiogram (ECG) at rest and 
during various modes and intensities of exercise. [4,5,6] 
Although HR chest belt systems are highly accurate, 
wearing a belt across the chest can be inconvenient for 
some users and may cause minor discomfort if worn for 
extended periods. To address these issues, wrist-worn 
devices have recently been developed for commercial use. 
These devices have implemented photoplethysmography 
(PPG) techniques to measure HR without the need for a 
chest belt. PPG is a non-invasive method for the detection 
of HR using a probe, typically light emitting diodes, to 
shine directly onto the skin and detect changes in the 
blood volume to determine HR. The PPG technique is 
based on the principle that blood flow through the artery is 
inversely related to the amount of light refracted. [7] 
Recent evidence suggests that the PPG method has 
acceptable validity in the measurement of HR during 
walking and running activities. [8] However, some studies 
[9,10] have reported that wrist-worn devices become less 
accurate in measuring HR as exercise intensity increases, 
possibly due to increases in upper body movement during 
faster running speeds, rather than an error in the device 
per se. In contrast, Stahl and colleagues [8] reported an 
increase in HR precision at raster running speeds, possibly 
due to an enhancement in blood perfusion. 
Studies that have indicated a reduction in the accuracy 
of wrist-worn HR devices as exercise intensity increases 
have tested the devices using fixed, rather than relative, 
intensities of exercise. [8,9,10] As exercise intensities for 
each participant were not prescribed relative to the level of 
CRF, this could influence the precision of the HR 
response due to participants performing exercise within 
different intensity domains. For example, running at a 
particular speed, could be within the moderate intensity 
domain for one individual; whereas the same speed could 
be vigorous, potentially non steady-state, exercise for an 
individual with a lower level of CRF.  
Current evidence suggests that the accuracy of  
wrist-worn HR devices is dependent on the device used 
and the intensity of exercise. However, no study to date 
has tested the accuracy of devices using relative exercise 
intensities. Additionally, it is unclear if the accuracy of 
HR readings is decreased when exercise intensity 
increases. Therefore, the aim of this study was to 
determine the accuracy of four popular wrist-worn devices 
(Apple Watch Series 1, Fitbit Charge 2, Mio Fuse and 
TomTom Touch) in measuring HR during incremental 
cycling at fixed, relative exercise intensities. 
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2. Methods 
2.1. Participants 
Eighteen healthy adults (16 males, 2 females) 
volunteered to participate in the study which was 
approved by St Mary’s University’s Ethics Committee. 
Mean ± s for age, height, body mass, and body mass index 
were: 30 ± 8 yrs, 1.76 ± 0.08 m, 75.3 ± 12.8 kg, and 24.1 
± 2.8 kg·m-2, respectively. Exclusion criteria included:  
(1) current use of any medications that influence the 
cardiovascular system; (2) presence of any known 
cardiorespiratory, neurological, musculoskeletal, or 
metabolic diseases or abnormalities; (3) being 
unaccustomed to regular (at least 75 minutes per week) 
vigorous exercise. Participants completed a medical 
history form and provided written informed consent 
before commencing the experimental procedures. 
2.2. Experimental Design 
All participants made three visits to the laboratory for 
data collection. Trial 1 consisted of a baseline assessment 
to establish resting HR, the relationship between HR and 
power output, and maximum HR (HRmax) for each 
participant. During trials 2 and 3, wrist-worn HR monitors 
were used alongside an electrocardiograph (ECG) system 
(Vyntus ECG, JAEGER, Würzburg, Germany) and  
chest-worn HR monitor (Polar S610i; Polar Electro Oy, 
Kempele, Finland). Participants were instructed not to  
eat or drink anything other than water in the three  
hours preceding each visit and to refrain from any 
strenuous PA and caffeine consumption for 24 hours 
before each visit. 
2.3. Baseline Assessment 
Upon arriving at the laboratory, each participant 
completed a medical history questionnaire and consent 
form. Height and body mass were measured, and a coded 
strap (Polar T31; Polar Electro Oy, Kempele, Finland) was 
fitted around the chest of each participant at the level of 
the xiphoid process. Following five minutes of seated, 
undisturbed rest, resting HR was recorded using the HR 
receiver. A validated prediction equation [11] was used to 
calculate predicted HRmax and 85% HRR for use in the 
comparative trials.  
The cycle ergometer (SRM, SRM International, Jülich, 
Germany) was adjusted for each participant at the start of 
the baseline assessment, with measurements noted for 
replication in subsequent trials. Participants then 
completed a submaximal step protocol consisting of six to 
nine 3-minute stages, with power output increasing by 20 
W at the start of each stage. The starting power output was 
selected by the investigator based on the reported training 
status of each participant, to enable the completion of a 
minimum of five and a maximum of nine stages before  
85% HRmax was achieved. All participants completed a 
minimum of five stages. Mean HR during the final 60 s of 
each stage was obtained using HR analysis software (Polar 
Precision Performance Software, Polar Electro, Oy, 
Finland). Following a five minute rest period, the 
participant performed a maximal ramp protocol on the 
cycle ergometer. The initial power output of the ramp test 
was the final power of sub-maximal test minus 30%, and 
was increased by 5 W at 15 s intervals. The test was 
terminated when the participant reached volitional 
exhaustion or cadence fell below 70 rpm. The HRmax 
achieved during the test was obtained using the HR 
analysis software.  
2.4. Comparative Trials 
During trials 2 and 3, each participant was fitted with 
two of the four wrist-worn devices (one on each wrist) 
using a randomised and counterbalanced method. The 
devices tested were the Apple Watch Series One (Apple 
Inc., California, United States), Fitbit Charge HR (Fitbit 
Inc., San Francisco, United States), TomTom Touch 
(TomTom International B.V., Amsterdam, The 
Netherlands), and Mio Fuse (Mio Global, Canada). The 
wrist-worn devices were fitted according to the 
instructions of each manufacturer. Prior to ECG electrode 
placement, the skin was prepared with an alcohol 
preparation pad and, where applicable, shaved with a 
disposable razor. Five silver-chloride electrodes (Ambu 
Ltd., Cambridgeshire, UK) where then placed on the 
anterior torso in a standard five-lead configuration and 
connected to the ECG system. Each participant then 
performed a submaximal, step protocol on the cycle 
ergometer, which consisted of five, 3-minute stages at 40, 
50, 60, 70, and 80% HRR (determined using linear 
regression from the submaximal HR responses in Trial 1). 
For consistency, and given that some of the wrist-worn 
devices did not have a facility to record HR continuously, 
HR data were recorded manually 10 s from the end of 
each stage. At the end of the final stage the participant 
rested passively on the cycle ergometer and recovery HR 
was recorded after 2 minutes. 
2.5. Statistical Analyses 
Data were analysed using the Statistical Package for the 
Social Sciences (IBM SPSS Statistics; Armonk, New 
York, USA). Measures of central tendency and spread are 
presented as means ± standard deviation. Relationships 
between ECG measures of HR and those of each of the 
alternative devices were determined using Pearson 
correlation coefficients with associated 95% confidence 
limits. The effects of exercise intensity on HR responses 
across the various HR devices were evaluated using a two-
way (device × exercise intensity) analysis of variance 
(ANOVA), with differences in HR between each device 
and the ECG response as the dependent variable. 
Differences in recovery HR between ECG and the various 
devices were evaluated using a one-way ANOVA, with 
differences in HR relative to ECG again used as the 
dependent variable. In line with previous research [5] 
comparing HR responses between ECG and a traditional 
HR monitor (Polar RS400; Polar Electro Oy, Kempele, 
Finland) differences in HR between ECG and the various 
devices ≥ 5 b·min-1 were considered to be outside of the 
normal range of variability. α was set at 0.05 for all 
analyses. 
 
 Journal of Physical Activity Research 114 
3. Results 
3.1. Heart Rates during Exercise 
There were no instances, across any of the exercise 
intensities, where ECG and Polar data differed by ≥ 5 
b·min-1. In contrast there were two instances (2.2%) with 
the Apple, four (4.4%) with the Mio Fuse, 19 (21.1%) 
with the Fitbit, and 10 (11.1%) with the TomTom. As 
such, 18 participants achieved a full data-set of HR 
responses that were < 5 b·min-1 of the ECG responses for 
the Polar, 16 for the Apple, 14 for the Mio Fuse, 10 for the 
Fitbit, and 12 for the TomTom. Only four participants 
achieved a full data set from all devices without any 
discrepancies ≥ 5 b·min-1 relative to ECG. Heart rate 
responses during exercise determined from all devices are 
presented in Table 1, with corresponding correlation 
coefficients between ECG and each device presented in 
Table 2. Relative to ECG, there were no significant 
differences in HR responses between the devices during 
exercise (F = 1.499; p = 0.239), and there was no device × 
exercise intensity interaction effect (F = 1.027; p = 0.370). 
There was, however, an effect of exercise intensity on HR 
responses relative to ECG (F = 3.637; p = 0.032), but post 
hoc tests were unable to identify where those differences 
were. 
3.2. Heart Rates during Recovery 
Heart rate responses at the end of the 2-minute recovery 
period from all devices are presented in Table 3, along 
with correlation coefficients between ECG and each 
device. There were no instances, at the end of the recovery 
period, where ECG and Polar data differed by ≥ 5 b·min-1. 
In contrast, there were five instances (27.8%) with the 
Apple, two (11.1%) with the Mio, two (11.1%) with the 
Fitbit, and three (16.7%) with the TomTom. Relative to 
ECG there were no significant differences between the 
devices in HR at the end of the recovery period (F = 2.847; 
p = 0.068). 
Table 1. Heart rates across a range of exercise intensities as determined by electrocardiogram (2 trials) and several other devices. Intensities 
are based on percentages of heart rate reserve. Values are means ± standard deviation 
Device 40% HRR 50% HRR 60% HRR 70% HRR 80% HRR 
ECG 1 (b·min-1) 111 ± 12 123 ± 16 134 ± 16 146 ± 16 156 ± 18 
Polar (b·min-1)* 111 ± 12 123 ± 16 135 ± 16 146 ± 16 157 ± 18 
Apple (b·min-1)* 111 ± 13 123 ± 161 134 ± 141 146 ± 16 157 ± 17 
Mio Fuse (b·min-1)* 111 ± 132 122 ± 161 134 ± 161 146 ± 16 156 ± 18 
ECG 2 (b·min-1) 111 ± 11 122 ± 14 134 ± 16 146 ± 15 158 ± 16 
Fitbit (b·min-1)† 106 ± 176 114 ± 196 132 ± 203 144 ± 182 158 ± 152 
TomTom (b·min-1)† 109 ± 124 118 ± 173 135 ± 161 146 ± 152 157 ± 15 
Note: HRR = heart rate reserve; ECG = electrocardiogram; * measured at same time as ECG 1; † measured at same time as ECG 2. Superscripted 
numbers indicate the number of instances where responses differed by ≥ 5 b·min-1 relative to ECG. 
Table 2. Correlation coefficients between heart rate responses measured by electrocardiogram versus several other devices across a range of 
exercises intensities based on percentages of heart rate reserve. Unless otherwise indicated, values are based on a sample size of 18 and include 
all data 
 ECG 
Device 40% HRR 50% HRR 60% HRR 70% HRR 80% HRR 
Polar 0.998 [0.995 – 0.999] 1.000 [1.000 – 1.000] 0.999 [0.997 – 1.000] 0.999 [0.997 – 1.000] 0.999 [0.997 – 1.000] 
Apple 0.995 [0.986 – 0.998] 0.984 [0.957 – 0.994] 0.958 [0.889 – 0.985] 0.995 [0.986 – 0.998] 0.995 [0.986 – 0.998] 
Mio 0.973 [0.927 – 0.990] 0.954 [0.878 – 0.983] 0.993 [0.981 – 0.997] 0.997 [0.992 – 0.999] 0.999 [0.997 – 1.000] 
Fitbit 0.895 [0.735 – 0.961] 0.620 [0.216 – 0.843] 0.931 [0.821 – 0.974] 0.904 [0.756 – 0.964] 0.987 [0.965 – 0.995] 
TomTom 0.963 [0.898 – 0.987]* 0.712 [0.352 – 0.889]* 0.997 [0.991 – 0.999]* 0.990 [0.972 – 0.996]* 0.997 [0.992 – 0.999] 
Note: ECG = electrocardiogram; HRR = heart rate reserve; * n = 17 (no data received from the device for one participant over the first four exercise 
intensities). Values in square brackets represent 95% confidence limits. 
Table 3. Heart rates after 2 minutes of recovery from a step incremental test as determined by electrocardiogram (2 trials) and several other 
devices, along with corresponding correlation coefficients between EGC and those same devices. Heart rate values are means ± standard 
deviation. n = 18 for all measures 
 ECG 1 Polar* Apple* Mio Fuse* ECG 2 Fitbit† TomTom† 
Heart rate (b·min-1) 100 ± 20 100 ± 20 103 ± 20 100 ± 20 100 ± 18 101 ± 18 99 ± 19 
Correlation coefficient - 0.998 [0.995 – 0.999] 
0.960 
[0.894 – 0.985] 
0.953 
[0.876 – 0.983] - 
0.990 
[0.973 – 0.996] 
0.938 
[0.838 – 0.977] 
Note: ECG = electrocardiogram; * heart rate measured at same time as ECG 1; † heart rate measured at same time as ECG 2. Values in square brackets 
represent 95% confidence limits.  
 
  
 
115 Journal of Physical Activity Research  
4. Discussion 
The aim of this study was to investigate the accuracy of 
four commercially available wrist-worn HR monitors. The 
results indicate that none of the wrist-worn HR monitors 
demonstrated the same level of accuracy as an ECG or 
chest-worn HR monitor. Therefore, in accordance with 
previous studies, a chest-worn HR device offers the best 
accuracy for the measurement of HR during exercise and 
recovery. [5,6,12] Although, relative to ECG, there were 
no significant differences in HR responses between any of 
the devices during exercise, the number of instances 
where the wrist-worn devices differed by ≥ 5 b·min-1 from 
ECG measurements raises some concerns over their level 
of precision. Overall, the Apple and Mio Fuse devices 
offered the greatest level of accuracy across the five 
exercise intensities (see Table 2).  
Previous wrist-worn HR monitor studies have 
suggested either an improvement [8], or a reduction [9,10] 
in precision as exercise intensity increases; the former 
attributed to increases in blood perfusion, and the latter to 
increased hand/wrist movement at faster running speeds. 
The present study is the first to investigate the precision of 
wrist-worn HR monitors during incremental exercise at 
various relative, rather than fixed, exercise intensities. 
Moreover, the use of cycling as the mode of exercise 
controlled for the risk of upper body movement 
influencing the measurements. Although, relative to ECG, 
there was a significant effect of exercise intensity on HR 
responses during exercise, that effect appears to be mostly 
attributable to a preponderance of errors (differences from 
ECG ≥ 5 b·min-1) with the Fitbit and TomTom devices at 
the lower exercise intensities (see Table 1 & Table 2). A 
reduction in the number of errors at the higher exercise 
intensities supports the possibility that device precision 
improves as blood perfusion increases. However, the fact 
that post hoc tests were unable to find significant 
differences between devices at each intensity, coupled 
with the absence of similar error responses with the Apple 
and Mio Fuse devices suggests that any such effect may 
be device-specific. 
Despite strong correlations with criterion measurements 
and the absence of statistically significant differences, the 
failure of the wrist-worn devices to consistently produce 
accurate HR readings is consistent with reports on similar 
devices [8,9,10]. Previous research has attributed 
inconsistencies in HR readings, in part, to artefacts from 
excessive hand/wrist movement during running [6,9]. 
However, the present study used cycling based exercise to 
avoid hand/wrist movements throughout the protocol, yet 
there were still several instances where HR values from 
the wrist-worn devices differed from ECG by ≥ 5 b·min-1. 
While it is not possible to determine whether the 
responses would have resulted in more errors if running 
had been chosen as the mode of exercise, research into the 
effects of exercise mode on the precision of wrist-worn 
devices is certainly warranted. 
Recovery HR is often measured during athletic training 
programmes [13], sometimes as a means of determining 
recovery duration during interval training [14]. Recovery 
HR is also measured in clinical practice as a prognostic 
marker [15,16]. Therefore, it is important that wrist-worn 
devices are sensitive to a rapid flux in HR. In the present 
study, the failure of the wrist-worn devices to consistently 
produce accurate HR readings in recovery, despite, as 
during exercise, strong correlations with ECG readings 
and the absence of significant differences, raises some 
concerns. Indeed, the frequency of errors in HR from the 
wrist-worn devices at the end of the recovery period 
provides credence to the hypothesis that the precision of 
wrist-worn devices may be influenced by blood perfusion.  
5. Conclusions 
Heart rate is commonly used to monitor and prescribe 
cardiovascular-based exercise for athletic [2] and clinical 
populations [17] and is also used to estimate CRF [3]. The 
results of the present study indicate that wrist-worn HR 
monitors offer an acceptable level of accuracy in 
measuring HR during cardiovascular exercise. However, it 
is recommended that a chest-worn HR monitor is used 
when accuracy is paramount across a range of exercise 
intensities. The present study indicated instances of 
random error in HR readings with wrist-worn devices 
which, in part, might be due to individual factors, such as 
blood perfusion. Therefore, individuals wishing to 
purchase a wrist-worn HR device should, ideally, compare 
the device with a chest-worn HR monitor to determine if 
the device offers acceptable precision during the 
PA/exercise that will routinely be performed. If a 
comparison between devices is not feasible then, based on 
the results of this study, the Apple Watch and Mio Fuse 
devices appear to provide the most valid measures of HR 
during cycling; with the latter providing the best all-round 
response. 
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